Compare Oscar Health Inc (OSCR) vs Raytheon Technologies Corp (RTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Raytheon Technologies Corp — how do they compare? Oscar Health Inc trades at $28.9 (market cap $9.28B), while Raytheon Technologies Corp trades at $194.5 (market cap $260.81B). The key difference: Raytheon Technologies Corp is far larger — about 28.1× Oscar Health Inc's market cap, and Raytheon Technologies Corp pays a 1.51% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| OSCR | RTX | |
|---|---|---|
Market Cap | $9.28B | $260.81B |
Sector | Health | Industrials |
52-Week High | $32.18 | $212.16 |
52-Week Low | $10.85 | $149.17 |
Enterprise Value | $4.90B | $292.93B |
Dividend Yield | — | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
RTX trades at $194.88, up 0.23% today, with a bullish technical signal and strong analyst support. Recent contract wins, including a $515 million Navy radar award (PRNewsWire, June 3, 2026), and expanding manufacturing capacity in Poland highlight growth momentum. The company has beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.78 surpassing the $1.51 forecast. Revenue growth accelerated to $88.6 billion in 2025, driving net income to $6.73 billion.
The outlook is positive, supported by robust defense spending and operational execution. However, a high P/E ratio of 36.34 suggests premium valuation, while rising long-term debt poses a financial risk. The stock offers a dividend yield of approximately 1.5%, with the next payment of $0.73 scheduled for September 3, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →
